Discover open access scientific publications

Search, annotate, share and cite publications

Figure 9 From: Moctezuma V, Sánchez-Huerta JL, Halffter G (2017) Two New Species of the Phanaeus Endymion Species Group (Coleoptera, Scarabaeidae, Scarabaeinae). ZooKeys 702: 113-135.

2017

English

Figure 9 From: Montoya AL, Wolff M (2020) Description of Five New Large Species of Argentinomyia Lynch-Arribálzaga, and Redescription of Talahua Fervida (Fluke) (Diptera, Syrphidae, Syrphinae). .

2020

English

Figures 3-9 From: Ji Q, Ren G (2019) Two New Species of the Genus Cyanopenthe Nikitsky, 1998 (Coleoptera, Tetratomidae) From Southwest China. ZooKeys 874: 19-30.

2019

English

A Human Cytomegalovirus Mutant Resistant to the Nucleoside Analog 9-([2-Hydroxy-1-(Hydroxymethyl)ethoxy]methyl)guanine (BW B759U) Induces Reduced Levels of BW B759U Triphosphate.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

1986

English

Book Review: ThrombosisThrombosis. VerstraeteM & VermylenJ Pp 339£25 ISBN 0-08-030799-X (H/Bk) £12 ISBN 0-08-031976-9 (P/Bk) Oxford: Pergamon Press1984

Journal of the Royal Society of Medicine

Medicine

1985

English

Rythme Circadien Des Acides Céto-9 Décène-2 Oïque, Phéromone De La Reine, Et Hydroxy-10 Décène-2 Oïque Des Ouvrières d'ABEILLES Apis Mellifica Ligustica S.

Apidologie

Insect Science

1978

English

Disialoganglioside (GD3) Synthase Gene Expression Suppresses Vascular Smooth Muscle Cell Responses via the Inhibition of ERK1/2 Phosphorylation, Cell Cycle Progression, and Matrix Metalloproteinase-9 Expression

Journal of Biological Chemistry

English

Increased Litter Size and Super-Ovulation Rate in Congenic C57BL Mice Carrying a Polymorphic Fragment of NFR/N Origin at the Fecq4 Locus of Chromosome 9

English

DEARDEN Philip and ROLLINS Rick Eds.: Parks and Protected Areas in Canada: Planning and Management Canada: Oxford University Press, 496 Pp., 2009 (ISBN 978-0-19-542734-9).

Geographical review of Japan series B

2010

English

Long-Term Treatment Adherence to the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Alirocumab in 6 ODYSSEY Phase III Clinical Studies With Treatment Duration of 1 to 2 Years

Journal of Clinical Lipidology

Cardiovascular Medicine

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Figure 9 From: Moctezuma V, Sánchez-Huerta JL, Halffter G (2017) Two New Species of the Phanaeus Endymion Species Group (Coleoptera, Scarabaeidae, Scarabaeinae). ZooKeys 702: 113-135.

Figure 9 From: Montoya AL, Wolff M (2020) Description of Five New Large Species of Argentinomyia Lynch-Arribálzaga, and Redescription of Talahua Fervida (Fluke) (Diptera, Syrphidae, Syrphinae). .

Figures 3-9 From: Ji Q, Ren G (2019) Two New Species of the Genus Cyanopenthe Nikitsky, 1998 (Coleoptera, Tetratomidae) From Southwest China. ZooKeys 874: 19-30.

A Human Cytomegalovirus Mutant Resistant to the Nucleoside Analog 9-([2-Hydroxy-1-(Hydroxymethyl)ethoxy]methyl)guanine (BW B759U) Induces Reduced Levels of BW B759U Triphosphate.

Book Review: ThrombosisThrombosis. VerstraeteM & VermylenJ Pp 339£25 ISBN 0-08-030799-X (H/Bk) £12 ISBN 0-08-031976-9 (P/Bk) Oxford: Pergamon Press1984

Rythme Circadien Des Acides Céto-9 Décène-2 Oïque, Phéromone De La Reine, Et Hydroxy-10 Décène-2 Oïque Des Ouvrières d'ABEILLES Apis Mellifica Ligustica S.

Disialoganglioside (GD3) Synthase Gene Expression Suppresses Vascular Smooth Muscle Cell Responses via the Inhibition of ERK1/2 Phosphorylation, Cell Cycle Progression, and Matrix Metalloproteinase-9 Expression

Increased Litter Size and Super-Ovulation Rate in Congenic C57BL Mice Carrying a Polymorphic Fragment of NFR/N Origin at the Fecq4 Locus of Chromosome 9

DEARDEN Philip and ROLLINS Rick Eds.: Parks and Protected Areas in Canada: Planning and Management Canada: Oxford University Press, 496 Pp., 2009 (ISBN 978-0-19-542734-9).

Long-Term Treatment Adherence to the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Alirocumab in 6 ODYSSEY Phase III Clinical Studies With Treatment Duration of 1 to 2 Years